53 related articles for article (PubMed ID: 17253640)
1. Clinical practice guideline-inconsistent management of fever and neutropenia in pediatric oncology: A Children's Oncology Group study.
Dupuis LL; Fisher BT; Sugalski AJ; Grimes AC; Nuño M; Ramakrishnan S; Beauchemin MP; Robinson PD; Santesso N; Walsh A; Wrightson AR; Yu L; Parsons SK; Sung L
Pediatr Blood Cancer; 2024 Apr; 71(4):e30880. PubMed ID: 38291716
[TBL] [Abstract][Full Text] [Related]
2. Time to antibiotics (TTA) in paediatric patients with fever in the setting of neutropenia.
Butt AJ; Kanwal F; Hafeez H; Nasir KS; Abrar W; Munawar M; Yaqub S
Clin Med (Lond); 2022 Jul; 22(Suppl 4):82-83. PubMed ID: 36220257
[No Abstract] [Full Text] [Related]
3. Efficacy of oral levofloxacin monotherapy against low-risk FN in patients with malignant lymphoma who received chemotherapy using the CHOP regimen.
Mogi A; Sasaki H; Nakashima Y; Chinen S; Ishizu M; Tanaka T; Takata T; Takamatsu Y
J Clin Exp Hematop; 2020 Sep; 60(3):73-77. PubMed ID: 32779614
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients.
Carlesse F; Cappellano P; Quiles MG; Menezes LC; Petrilli AS; Pignatari AC
BMC Infect Dis; 2016 Sep; 16(1):462. PubMed ID: 27585633
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of reduced therapy regimens for children with low risk febrile neutropenia.
Morgan JE; Cleminson J; Atkin K; Stewart LA; Phillips RS
Support Care Cancer; 2016 Jun; 24(6):2651-60. PubMed ID: 26757936
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Antimicrobial Sensitivity to Older and Newer Quinolones versus Piperacillin-Tazobactam, Cefepime and Meropenem in Febrile Patients with Cancer in two Referral Pediatric Centers in Tehran, Iran.
Nateghian A; Robinson J; Vosough P; Navidinia M; Malekan M; Mehrvar A; Sobouti B; Bahadoran P; Gholinejad Z
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014045. PubMed ID: 25045453
[TBL] [Abstract][Full Text] [Related]
7. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Ben Dor I; Paul M; Eliakim-Raz N; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003992. PubMed ID: 24105485
[TBL] [Abstract][Full Text] [Related]
8. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.
Manji A; Beyene J; Dupuis LL; Phillips R; Lehrnbecher T; Sung L
Support Care Cancer; 2012 Jun; 20(6):1135-45. PubMed ID: 22402749
[TBL] [Abstract][Full Text] [Related]
9. Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients.
Rolston KV; Frisbee-Hume SE; Patel S; Manzullo EF; Benjamin RS
Support Care Cancer; 2010 Jan; 18(1):89-94. PubMed ID: 19387695
[TBL] [Abstract][Full Text] [Related]
10. The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model.
Sansone JM; Wilsman NJ; Leiferman EM; Conway J; Hutson P; Noonan KJ
J Pediatr Orthop; 2009 Mar; 29(2):189-95. PubMed ID: 19352246
[TBL] [Abstract][Full Text] [Related]
11. Febrile neutropenia in children with cancer.
Paulus S; Dobson S
Adv Exp Med Biol; 2009; 634():185-204. PubMed ID: 19280859
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
13. Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.
Rolston KV; Manzullo EF; Elting LS; Frisbee-Hume SE; McMahon L; Theriault RL; Patel S; Benjamin RS
Cancer; 2006 Jun; 106(11):2489-94. PubMed ID: 16628654
[TBL] [Abstract][Full Text] [Related]
14. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
Cooper MR; Durand CR; Beaulac MT; Steinberg M
Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
Mullen CA
Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
[TBL] [Abstract][Full Text] [Related]
16. Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia.
Petrilli A; Altruda Carlesse F; Alberto Pires Pereira C
Pediatr Blood Cancer; 2007 Oct; 49(5):682-6. PubMed ID: 17253640
[TBL] [Abstract][Full Text] [Related]
17. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
